Company page

Prelude Therapeutics Incorporated

Prelude Therapeutics Incorporated, trading under the ticker PRLD, is a public company based in the United States with a market capitalization of approximately $305 million. The company focuses on developing innovative therapies for cancer treatment. Prelude Therapeutics is committed to advancing its pipeline of drug candidates to address unmet medical needs in oncology.